Lewis Cantley, PhD's Lecture at STO Meeting 2010
Phosphoinositide 3-Kinase (PI3K) is a central enzyme in a signaling pathway that mediates cellular responses to growth factors and turning off PI 3-kinase with PI3K inhibitors that are in human clinical trials results in an acute decline in FDG-PET signal
Ещё видео!